THE CARBON MONOXIDE DONOR, TOPIRAMATE, AND BLOCKERS OF AQUAPORINE RECEPTORS DECREASE MYOCARDIAL ISCHEMIA-REPERFUSION INJIRY
S.P. Beschasnyi, O.M. Hasiuk
Kherson State University, Ukraine
DOI: https://doi.org/10.15407/fz67.05.030
Abstract
We investigated the metabolism of mouse isolated heart
under the influence of tricarbonyldichlorothenium (II)-
dimer (CORM-2 and 2,3-4,5-bis-O-isopropylidene-βD-fructopyranose sulfamate (topiramate) as potential
blockers of aquaporine channel (AQP3) of cardiac myocytes. The results were compared with those obtained
from the group receiving anti-AQP3 monoclonal antibodies. A decrease in coronary flow was found during
the period preceding ischemia (topiramate did not cause
this effect). However, at the end of reperfusion, CORM-2
was responsible for its stabilization. This compound did
not affect glucose intake (topiramate increased it only
at the end of reperfusion), decreased Ca2+ deposition in
cardiac muscle (AQP3-IgG antibodies and topiramate
had similar effect), decreased creatinine release, AST
(especially at the end of reperfusion). The action of
CORM-2 increased the amplitude of the R waveform
before ischemia and during reperfusion. At the end of
reperfusion the R-wave amplitude decreased. The effect
of topiramate caused an increase in amplitude only at the
beginning of reperfusion. Administration of CORM-2,
topiramate and antibodies resulted in prolongation of
the interval before and during ischemia. At the same
time, the effect of these drugs and antibodies reduced the
development of ischemic damage. The results indicate
that the released CO from CORM-2 has effects similar to
those of anti-AQP3 antibodies. The action of topiramate
had signs of calcium channel blocking.
Keywords:
aquaporins; AQP3; gas-transmitter; carbon monoxide donor; CORM-2; isolated heart; topiramat
References
- Sagach VF, Dorofeyeva NA, Drachuk KO. Contribution of hydrogen sulfide to cardio-vascular function restoration in old rats. J Mol Cell Cardiol. 2018;120:35.
CrossRef
- Panneerselvam L, Raghunath A, Perumal E. Differential expression of myocardial heat shock proteins in rats acutely exposed to fluoride. Cell Stress Chaperones. 2017;22:743-50.
CrossRef
PubMed PubMedCentral
- Ling K, Men F, Wang WC, Zhou YQ, Zhang HW, Ye DW. Carbon monoxide and its controlled release: therapeutic application, detection, and development of carbon monoxide releasing molecules (CORMs) miniperspective. J Med Chem. 2017;61(7):2611-35.
CrossRef
PubMed
- Queiroga CS, Almeida AS, Alves PM, Brenner C, Vieira HL Carbon monoxide prevents hepatic mitochondrial membrane permeabilization. BMC Cell Biol. 2011;12:1-8.
CrossRef
PubMed PubMedCentral
- Beschasnyi S, Hasiuk O. CO-releasing molecule (CORM-2) in the regulation of Ca2+-dependent K+-permeability of erythrocyte. Ukr Zh Med Bìol Sportu. 2020;5(2),166-71.
CrossRef
- Kukoba TV, Moybenko OO, Kotsjuruba AV. Cardioprotective effect of heme oxigenase-1 induction by hemin on the isolated heart of rat at ischemia/reperfusion. Fiziol Zh. 2003;49(6):14-21. [Ukrainian].
- Johnson TE, Wells RJ, Bell A, Nielsen VG, Olver CS. Carbon monoxide releasing molecule enhances coagulation and decreases fibrinolysis in canine plasma exposed to Crotalus viridis venom in vitro and in vivo. Basic Clin Pharmacol Toxicol. 2019;125(4):328-36.
CrossRef
PubMed
- Motterlini R, Foresti R. Biological signaling by carbon monoxide and carbon monoxide-releasing molecules. Am J Physiol Cell Physiol. 2017;312(3):302-13.
CrossRef
PubMed
- Beschasnyi SP, Hasiuk OM. The effect of carbon monoxide's donor CORM-2 on erythrocyte aquaporins. World Med Biol. 2021;17(76):167-73.
CrossRef
Ikarashi N, Aburada T, Kon R, Sugiyama K. Water control mechanism of byakkokaninjinto and its active components via aquaporins. Traditional Kampo Med. 2019;6(2):57-61. Material nadiishov do redaktsii 17.08.2021
CrossRef
- Ma T, Hara M, Sougrat R, Verbavatz JM, Verkman AS. Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3. J Biol Chem. 2002;277:17147-53.
CrossRef
PubMed
- Verkman AS, Anderson MO, Papadopoulos MC. Aquaporins: important but elusive drug targets. Nat Rev Drug Discov. 2014;13(4):259-77.
CrossRef
PubMed PubMedCentral
- Kitchen P, Day RE, Salman MM, Conner MT, Bill RM, Conner AC. Beyond water homeostasis: Diverse functional roles of mammalian aquaporins. Biophys Acta Gen Subj. 2015;1850(12):2410-21.
CrossRef
PubMed
Bollag WB, Aitkens L, White J, Hyndman KA. Aquaporin-3 in the epidermis: more than skin deep. Am J Physiol Cell Physiol. 2020;318(6):C1144-53
CrossRef
PubMed PubMedCentral
- Rutkovsky A, Stenslokken KO, Kaljusto M-L, Hafstad A, Larsen T, Vaage J. Degree of phosphorylation of survival kinases in isolated mouse hearts depends on the mode of perfusion. J Mol Cell Cardiol. 2008;44:809.
CrossRef
- Abir-Awan M, Kitchen P, Salman MM, Conner MT, Conner AC, Conner AC, Bill RM. Inhibitors of mammalian aquaporin water channels. Int J Mol Sci. 2019;20(7):1589.
CrossRef
PubMed PubMedCentral
- Butler TL, Au CG, Yang B, Egan JR, Tan YM, Hardeman EC, Winlaw DS. Cardiac aquaporin expression in humans, rats, and mice. Am J Physiol Heart Circ Physiol. 2006;291(2):H705-13.
CrossRef
PubMed
- Kazory A, Ronco C. Are we barking up the wrong tree? Rise in serum creatinine and heart failure. Blood Purif. 2019;48(3):193-5.
CrossRef
PubMed
- Alyasin A, Momeni HR, Mahdieh M. Aquaporin 3 expression and the potential role of aquaporins in motility and mitochondrial membrane potential in human spermatozoa. Andrologia. 2020;52(6):e13588.
CrossRef
- Takashi Y, Tomita K, Kuwahara Y, Roudkenar MH, Roushandeh AM, Igarashi K, Sato T. Mitochondrial dysfunction promotes aquaporin expression that controls hydrogen peroxide permeability and ferroptosis. Free Radic Biol Med. 2020;161:60-70.
CrossRef
PubMed PubMedCentral
|